Leucine rich repeat containing 75B (LRRC75B) is a protein encoded by the LRRC75B gene, situated within the human genome. The designation "LRRC" indicates that the protein contains leucine-rich repeat (LRR) domains. LRRs are typically 20-29 amino acid sequence motifs that are rich in the amino acid leucine. These motifs are involved in the formation of a protein structure that is conducive to protein-protein interactions, often contributing to the assembly of various multiprotein complexes.
The LRRC75B protein, by virtue of its leucine-rich domains, is presumed to engage in such interactions, which could have implications for various cellular functions, including signal transduction, cell adhesion, and the immune response. LRR-containing proteins are known to be versatile in their functions, participating in a wide range of biological processes. However, the specific roles of LRRC75B in these processes are not well-documented and are likely to be complex and multifaceted.The structure of LRRC75B, with its characteristic LRR domains, suggests a potential role in molecular recognition and binding, which are critical in cellular communication and signaling pathways. The exact pathways and interactions involving LRRC75B, as well as its expression patterns in different cell types and tissues, remain areas of active investigation. Understanding these aspects could provide insights into the physiological functions of the protein and its possible involvement in human diseases.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-beta is involved in cell growth and differentiation, which might intersect with the function of LRR-containing proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitors affect protein degradation pathways and could influence the turnover of proteins like LRRC75B. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
These inhibitors can alter chromatin structure and potentially influence the expression of genes encoding LRR-containing proteins. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Kinase inhibitors can affect signal transduction pathways, potentially impacting LRR-containing proteins. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid influences cell differentiation and might impact the function of LRR-containing proteins. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
DNA damaging agents can activate cellular repair pathways, potentially involving LRR-containing proteins. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
These drugs can affect cellular signaling, potentially impacting proteins involved in these pathways, including LRR-containing proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitors affect cell growth and metabolism, potentially influencing the function of LRR-containing proteins. |